Yeşil A - Search Results

1

Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.

Sezikli M, Çetinkaya ZA, Güzelbulut F, Yeşil A, Coşgun S, Kurdaş OÖ. Sezikli M, et al. Among authors: yesil a. J Clin Pharm Ther. 2012 Jun;37(3):282-5. doi: 10.1111/j.1365-2710.2011.01286.x. Epub 2011 Jul 11. J Clin Pharm Ther. 2012. PMID: 21740452 Clinical Trial.

2

Effects of alpha tocopherol and ascorbic acid on Helicobacter pylori colonization and the severity of gastric inflammation.

Sezikli M, Çetinkaya ZA, Güzelbulut F, Çimen B, Özcan Ö, Özkara S, Yeşil A, Gümrükçü G, Ipçioğlu OM, Sezikli H, Ovünç AO. Sezikli M, et al. Among authors: yesil a. Helicobacter. 2012 Apr;17(2):127-32. doi: 10.1111/j.1523-5378.2011.00925.x. Helicobacter. 2012. PMID: 22404443 Clinical Trial.

3

Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naïve Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study.

Sezikli M, Cetinkaya ZA, Güzelbulut F, Yeşil A, Alt Nöz ME, Ulu N, Ovünç Kurdaş AO. Sezikli M, et al. Among authors: yesil a. Gut Liver. 2012 Jan;6(1):41-4. doi: 10.5009/gnl.2012.6.1.41. Epub 2012 Jan 12. Gut Liver. 2012. PMID: 22375169 Free PMC article.

4

Evaluation of colorectal adenocarcinomas at single-institution with respect to microsatellite instability.

Ozkara S, Sari B, Yesil A, Aktekin A, Sezikli M, Cetinkaya Z, Aker F. Ozkara S, et al. Among authors: yesil a. Chirurgia (Bucur). 2013 Jul-Aug;108(4):473-7. Chirurgia (Bucur). 2013. PMID: 23958088 Free article.

5

Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease.

Yesil A, Yilmaz Y. Yesil A, et al. Aliment Pharmacol Ther. 2013 Nov;38(9):1038-44. doi: 10.1111/apt.12489. Epub 2013 Sep 11. Aliment Pharmacol Ther. 2013. PMID: 24024834 Free article. Review.

6

Letter: gut microbiota modulation contributes to coffee's benefits for non-alcoholic fatty liver disease - authors' reply.

Yesil A, Yilmaz Y. Yesil A, et al. Aliment Pharmacol Ther. 2014 Jun;39(12):1442. doi: 10.1111/apt.12785. Aliment Pharmacol Ther. 2014. PMID: 24849166 Free article. No abstract available.

7

Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls.

Altunöz ME, Senateş E, Yeşil A, Calhan T, Ovünç AO. Altunöz ME, et al. Among authors: yesil a. Dig Dis Sci. 2012 Apr;57(4):1039-44. doi: 10.1007/s10620-011-1980-8. Epub 2011 Dec 7. Dig Dis Sci. 2012. PMID: 22147248 Clinical Trial.

8

Evaluation of leptin and insulin resistance in patients with cholelithiasis.

Atamer A, Ovünç AO, Yeşil A, Atamer Y. Atamer A, et al. Among authors: yesil a. Indian J Biochem Biophys. 2013 Aug;50(4):266-72. Indian J Biochem Biophys. 2013. PMID: 24772944

9

Neuroendocrine/squamous gastric collision tumor: A rare entity.

Erkol B, Tilki M, Comunoğlu N, Öven Ustaalıoğlu BB, Aker F, Sürmelioğlu A, Telli F, Gemici C, Kılıçoğlu ZG, Yeşil A. Erkol B, et al. Among authors: yesil a. Turk J Gastroenterol. 2014 Dec;25 Suppl 1:282-3. doi: 10.5152/tjg.2014.5425. Turk J Gastroenterol. 2014. PMID: 25910342 Free article. No abstract available.

10

Red cell distribution width: a novel marker of activity in inflammatory bowel disease.

Yeşil A, Senateş E, Bayoğlu IV, Erdem ED, Demirtunç R, Kurdaş Övünç AO. Yeşil A, et al. Gut Liver. 2011 Dec;5(4):460-7. doi: 10.5009/gnl.2011.5.4.460. Epub 2011 Nov 21. Gut Liver. 2011. PMID: 22195244 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page